GC Pharma Files IND for Hyperimmune Globulin-based Therapy for COVID-19

Clinical Research |  News | 0 Comment | 03 Aug, 2020

Korean biotech, GC has applied for an investigational new drug application (IND) to conduct a Phase 2 clinical trial for...Read more

AstraZeneca's AZD1222 expresses robust immune responses in Phase I/II trial

Clinical Research |  News | 0 Comment | 22 Jul, 2020

Interim results from the ongoing Phase I/II COV001 trial, led by Oxford University, showed AZD1222 was tolerated and gen...Read more

Celltrion launches human trial of potential COVID-19 Ab treatment

Clinical Research |  News | 0 Comment | 23 Jul, 2020

South Korea based Celltrion Group has announced the launch of its Phase I human clinical trial investigating a potential...Read more

Singapore approves clinical trial application for LUNAR-COV19 vaccine

Clinical Research |  News | 0 Comment | 23 Jul, 2020

US based Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the di...Read more

Avance Clinical Contracted for Atossa Therapeutics AT-301 Nasal Spray Clinical Study

Clinical Research |  News | 0 Comment | 22 Jul, 2020

The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Av...Read more

BellaSeno initiates human trials of 'absorbable soft tissue reconstruction scaffold (Senella)'

Clinical Research |  News | 0 Comment | 21 Jul, 2020

BellaSeno GmbH, an ISO 13485-certified clinical-stage medtech company developing absorbable scaffolds using additiv...Read more

Avance Clinical Wins Frost & Sullivan “2020 Asia-Pacific CRO Market Leadership Award”

Clinical Research |  News | 0 Comment | 09 Jul, 2020

The leading Australian CRO for biotechs, Avance Clinical, accepted the prestigious Frost & Sullivan 2020 Asia-Pacifi...Read more

Evive Biotech meets promising results at Global Ph III trial for neutropenia treatment

Clinical Research |  News | 0 Comment | 08 Jul, 2020

Evive Biotech, a global biologics company developing novel biological therapies, is delighted to announce that its pivot...Read more

Lipidor, Cadila to conduct Ph III study of anti-psoriasis candidate

Clinical Research |  News | 0 Comment | 08 Jul, 2020

Swedish firm Lipidor AB has announced an agreement with Cadila Pharmaceuticals, a leading Indian pharmaceutical compan...Read more

Alterity meets US FDA for ATH434 pathway to treat Multiple System Atrophy

Clinical Research |  News | 0 Comment | 30 Jun, 2020

Alterity Therapeutics announced that it has received guidance from the US Food and Drug Administration (FDA) in relation...Read more

Panthera, Rutherford Health launch innovative oncology clinical trial network

Clinical Research |  News | 0 Comment | 25 Jun, 2020

Panthera and Rutherford Health plc have entered a collaboration to create a network of world-class clinical trial sites ...Read more

Novotech partners with PNUH to strengthen clinical trials

Clinical Research |  News | 0 Comment | 25 Jun, 2020

The leading Asia-Pacific biotech specialist CRO Novotech has partnered with South Korea’s world-class 1,...Read more

India to Lead ‘World’s Largest’ Convalescent Plasma COVID-19 Clinical Trial

Clinical Research |  News | 0 Comment | 14 Jun, 2020

Government Medical College and Hospital (GMCH) of Nagpur, Maharastra, India, will serve as the lead site for the “...Read more

TrialTrove Data Shows Australia is Open for Business says Avance Clinical

Clinical Research |  News | 0 Comment | 10 Jun, 2020

The leading Australian CRO for biotechs, Avance Clinical announced at BIO Digital on 10 June 2020 that Australia current...Read more

Avance reports 34% rise in clinical trials in Aus, NZ

Clinical Research |  News | 0 Comment | 12 May, 2020

The Australian CRO, Avance Clinical, said there was a 34% increase in the number of international trials registered in A...Read more

Daewoong reveales Ph 3 data of novel gastroesophageal reflux disease agent

Clinical Research |  News | 0 Comment | 11 May, 2020

Daewoong Pharmaceutical (Daewoong) from South Korea unveiled for the first time the phase 3 clinical data of Fexupr...Read more

TWiB receives Canada Health Approval for potential vitiligo drug

Clinical Research |  News | 0 Comment | 07 May, 2020

Taiwan based TWi Biotechnology (TWiB) announced that they have received Clinical Trial Application (CTA) approval f...Read more

Phase II trial evaluating Kevzara looks promising to fight COVID-19

Clinical Research |  News | 0 Comment | 05 May, 2020

Regeneron and Sanofi recently announced the preliminary results from the Phase II portion of an ongoing Phase II/III tri...Read more